Phase II study of individualized sunitinib as first-line therapy for metastatic renal cell cancer (mRCC).

被引：8
|
作者：
Bjarnason, Georg A.
Knox, Jennifer J.
Kollmannsberger, Christian K.
Soulieres, Denis
Ernst, D. Scott
Canil, Christina M.
Winquist, Eric
Zalewski, Pawel
Hotte, Sebastien J.
North, Scott A.
Heng, Daniel Yick Chin
Macfarlane, Robyn Jane
Venner, Peter M.
Tannock, Ian
Kapoor, Anil
Eigl, Bernhard J.
Hansen, Aaron Richard
Czaykowski, Piotr
Boyd, Ben
Basappa, Naveen S.
机构：
[1] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] BC Canc Agcy, Vancouver Canc Ctr, Vancouver, BC, Canada
[4] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[5] London Reg Canc Ctr, London, ON N6A 4L6, Canada
[6] Ottawa Reg Canc Ctr, Manotick, ON, Canada
[7] London Hlth Sci Ctr, London, ON, Canada
[8] Lakeridge Hlth, Oshawa, ON, Canada
[9] Juravinski Canc Ctr, Hamilton, ON, Canada
[10] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[11] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[12] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
[13] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada
[14] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada
[15] BC Canc Agcy, Vancouver, BC, Canada
[16] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[17] CancerCare Manitoba, Winnipeg, MB, Canada
[18] Ozmosis Res Inc, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.4555
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4555
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer.
    Bjarnason, Georg A.
    Knox, Jennifer J.
    Kollmannsberger, Christian K.
    Soulieres, Denis
    Ernst, D. Scott
    Zalewski, Pawel
    Canil, Christina M.
    Winquist, Eric
    Hotte, Sebastien J.
    North, Scott A.
    Heng, Daniel Yick Chin
    Macfarlane, Robyn Jane
    Venner, Peter M.
    Kapoor, Anil
    Hansen, Aaron Richard
    Eigl, Bernhard J.
    Czaykowski, Piotr
    Boyd, Ben
    Wang, Lisa
    Basappa, Naveen S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Phase II study of individualized sunitinib (SUN) as first-line therapy for metastatic renal cell cancer: Pharmacokinetic data
    Bjarnason, G. A.
    Knox, J.
    Kollmannsberger, C. K.
    Soulieres, D.
    Ernst, D. S.
    Zalewski, P.
    Canil, C. M.
    Winquist, E.
    Hotte, S. J.
    North, S. A.
    Heng, D. Y. C.
    Macfarlane, R. J.
    Venner, P. M.
    Kapoor, A.
    Hansen, A. R.
    Czaykowski, P.
    Boyd, B.
    Wang, L.
    Basappa, N. S.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [3] A phase II multicenter study of the efficacy and safety of sunitinib given on an individualized schedule as first-line therapy for metastatic renal cell cancer.
    Bjarnason, Georg A.
    Basappa, Naveen S.
    Knox, Jennifer J.
    Kollmannsberger, Christian K.
    Reaume, M. Neil Neil
    Lalewski, Pawel
    Macfarlane, Robyn Jane
    MacKenzie, Mary J.
    Hotte, Sebastien J.
    Heng, Daniel Vick Chin
    Soulieres, Denis
    Miller, Jessie
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [4] A PHASE IV MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF SUNITINIB AS FIRST-LINE THERAPY IN CHINESE PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)
    Qin, S.
    Jin, J.
    Guo, J.
    Wang, J.
    Zhou, F.
    Huang, Y.
    Ren, X.
    Ye, D.
    Wang, Q.
    Pan, S.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 282 - 282
  • [5] Sunitinib still first-line therapy for metastatic renal cancer
    Bagcchi, Sanjeet
    [J]. LANCET ONCOLOGY, 2014, 15 (10): : E420 - E420
  • [6] Prognostic factors for overall survival with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma (mRCC)
    Patil, S.
    Figlin, R. A.
    Hutson, T. E.
    Michaelson, M. D.
    Negrier, S.
    Kim, S. T.
    Huang, X.
    Motzer, R. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] A personalized sunitinib (S) first-line approach in elderly patients with metastatic renal cell carcinoma (mRCC).
    Rocca, Maria Cossu
    Iacovelli, Roberto
    Verri, Elena
    Crescio, Claudia
    Aurilio, Gaetano
    Detti, Serena
    Cullura, Daniela
    Nole, Franco
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [8] Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
    Vazquez, Sergio
    Leon, Luis
    Fernandez, Ovidio
    Lazaro, Martin
    Grande, Enrique
    Aparicio, Luis
    [J]. ADVANCES IN THERAPY, 2012, 29 (03) : 202 - 217
  • [9] Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
    Sergio Vázquez
    Luis León
    Ovidio Fernández
    Martín Lázaro
    Enrique Grande
    Luis Aparicio
    [J]. Advances in Therapy, 2012, 29 : 202 - 217
  • [10] Proteinuria with first-line therapy of metastatic renal cell cancer
    Land, Josiah D.
    Chen, Adrienne H.
    Atkinson, Bradley J.
    Cauley, Diana H.
    Tannir, Nizar M.
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2016, 22 (02) : 235 - 241
12345